The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
fosaprepitant dimeglumine · Injection
3 marketed package NDCs · 3 active manufacturers
Most dispensed: 150 mg/5mL · Injection, Powder, Lyophilized, For Solution · #1 vial, single-dose/carton / 5 ml in 1 vial, single-dose · 150 mg/5mL · Injection, Powder, Lyophilized, For Solution · #1 vial/carton / 5 ml in 1 vial · 1 kg/kg · Powder · #1 kg/drum · 1 kg/kg · Powder · #5 kg/drum
Same drug class
Other molecules FDA puts in Substance P/Neurokinin-1 Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Fosaprepitant dimeglumine in shortage right now?
- No. FDA does not currently list Fosaprepitant dimeglumine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Fosaprepitant dimeglumine?
- 25 companies have marketed Fosaprepitant dimeglumine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.